Satellos Bioscience Inc.
MSCLF
$0.4284
$0.01934.72%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 4.07M | 4.54M | 3.95M | 2.39M | 3.36M |
| Gross Profit | -4.07M | -4.54M | -3.95M | -2.39M | -3.36M |
| SG&A Expenses | 1.93M | 1.94M | 1.63M | 1.32M | 1.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.37M | 6.48M | 5.58M | 3.71M | 4.89M |
| Operating Income | -6.37M | -6.48M | -5.58M | -3.71M | -4.89M |
| Income Before Tax | -5.58M | -6.08M | -4.36M | -6.63M | -4.42M |
| Income Tax Expenses | 32.00K | 63.00K | -- | -- | -- |
| Earnings from Continuing Operations | -5.61M | -6.14M | -4.36M | -6.63M | -4.42M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -5.61M | -6.14M | -4.36M | -6.63M | -4.42M |
| EBIT | -6.37M | -6.48M | -5.58M | -3.71M | -4.89M |
| EBITDA | -6.37M | -6.48M | -5.57M | -3.71M | -4.89M |
| EPS Basic | -0.03 | -0.04 | -0.04 | -0.06 | -0.04 |
| Normalized Basic EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| EPS Diluted | -0.03 | -0.04 | -0.04 | -0.06 | -0.04 |
| Normalized Diluted EPS | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 |
| Average Basic Shares Outstanding | 171.23M | 165.82M | 120.50M | 113.03M | 112.80M |
| Average Diluted Shares Outstanding | 171.23M | 165.82M | 120.50M | 113.03M | 112.80M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |